Assembly Pharmaceuticals' Merger

Assembly Pharmaceuticals raised a round of funding on May 19, 2014. Investors include Ventrus Biosciences.

Assembly Pharmaceuticals is a virology-focused biopharmaceutical company with a discovery platform and programs based on proprietary Core Protein Allosteric Modulators (CpAMs) for the treatment of vir…

Articles about Assembly Pharmaceuticals' Merger: